Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

The following abstracts of articles from leading journals and from the ABOG recertification examination have been selected on the basis of their importance to the practice of obstetrics and gynecology. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* BACKGROUND: C-reactive protein (CRP) and low-density lipoprotein (LDL) cholesterol levels are both elevated in persons at risk for cardiovascular (CV) events. However, data directly comparing these two biologic markers are not available. METHODS: CRP and LDL cholesterol were measured at base line in 27,939 healthy American women. These women were then followed for a mean of eight years for the occurrence of myocardial infarction, ischemic stroke, coronary revascularization, or death from CV causes. The initial levels of CRP and LDL were analyzed to determine if they predicted the risk of CV events in the study population. RESULTS: Base line levels of both CRP and LDL cholesterol had a strong linear relation to the incidence of CV events. After adjustment for age, smoking, diabetes, blood pressure, and HRT, the relative risks of a first CV event, by quintile of CRP levels were 1.4, 1.6, 2.0, and 2.3 (P 0.001). The corresponding risks by quintile level for LDL cholesterol were 0.9, 1.1, 1.3, and 1.5 (P 0.001). Overall, 77 percent of CV events occurred in women with LDL cholesterol 160 mg per deciliter. Screening for both markers provided better prognostic information than screening for either alone. CONCLUSIONS: These data suggest that CRP levels are a stronger predictor of CV events than LDL cholesterol levels. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. N Engl J Med

[1]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[2]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[3]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Murray Wm Inflammation, aspirin, and the risk of cardiovascular disease. , 1997 .

[5]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[6]  R J Glynn,et al.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.

[7]  J. Manson,et al.  Hormone replacement therapy and increased plasma concentration of C-reactive protein. , 1999, Circulation.

[8]  R. Ross Atherosclerosis is an inflammatory disease , 1999 .

[9]  E. Barrett-Connor,et al.  Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.

[10]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[11]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[12]  E. Ford,et al.  Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Strachan,et al.  C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. , 2000, European heart journal.

[14]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[15]  Natalia S. Rost,et al.  Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.

[16]  P. Ridker,et al.  Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.

[17]  N Rifai,et al.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. , 2001, Clinical chemistry.

[18]  P. Ridker Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial. , 2001, European heart journal.

[19]  R B D'Agostino,et al.  Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop , 2001, Circulation.

[20]  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[21]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[22]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[23]  J. Manson,et al.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.

[24]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[25]  Paul M. Ridker,et al.  Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death , 2002, Circulation.

[26]  J. Manson,et al.  Is C-Reactive Protein Specific for Vascular Disease in Women? , 2002, Annals of Internal Medicine.

[27]  A. Exley,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.